Identification of cells expressing cyclooxygenase-2 in response to interleukin-1β in rat aortae

Journal of Pharmacological Sciences

Volumn 113, Issue 1, 2010, Pages 84-88

  Nakano, Tomoyuki ^a   Wakabayashi, Ichiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Cyclooxygenase 2; Remodeling; Vascular smooth muscle

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA;

ADVENTITIA; ANIMAL CELL; AORTA STRIP; ARTICLE; CELL CULTURE; ENDOTHELIUM; ENZYME LOCALIZATION; FIBROBLAST; IMMUNE RESPONSE; MACROPHAGE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER;

EID: 77953529581     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09337SC     Document Type: Article

References (15)

1. Gilroy DW, Colville-Nash PR. New insights into the role of COX 2 in inflammation. J Mol Med. 2000;78:121-129.
2. Vanhoutte PM. COX-1 and vascular disease. Clin Pharmacol Ther. 2009;86:212-215.
3. Feng L, Sun WQ, Xia YY, Tang WW, Chanmugam P, Soyoola E, et al. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys. 1993;307: 361-368.
4. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286: 954-959.
5. Frankish H. Why do COX-2 inhibitors increase risk of cardiovascular events? Lancet. 2002;359:1410.
6. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, et al. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest. 2002;110:61-69.
7. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, et al. Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest. 2004;114:784-794.
8. Wakabayashi I, Nakano T, Takahashi Y. Enhancement of interleukin-1β -induced iNOS expression in cultured vascular smooth muscle cells of Goto-Kakizaki diabetes rats. Eur J Pharmacol. 2010;629:1-6.
9. Richman JG, Regan JW. β2 -Adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells. Am J Physiol. 1998;274:C654-C662.
10. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
11. Stemme V, Swedenborg J, Claesson H, Hansson GK. Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries. Eur J Vasc Endovasc Surg. 2000;20:146-152.
12. Takahashi Y, Wakabayashi I. Depression of cyclooxygenase-2 induction in aortas of rats with type 1 and type 2 diabetes mellitus. Eur J Pharmacol. 2008;595:114-118.
13. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006;116:4-15.
14. Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA. Temporal control of NF- κB activation by ERK differentially regulates interleukin-1β -induced gene expression. J Biol Chem. 2004;279:1323-1329.
15. Roy J, Kazi M, Hedin U, Thyberg J. Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2. Differentiation. 2001;67:50-58.